Abstract：A 4-month-old girl developed convulsion in the neonatal period, which was focal motor seizures in the initial stage and later became spasm and tonic spasm. And the girl also had psychomotor retardation and recurrent pulmonary infection. Electroencephalography showed hypsarrhythmia, normal results were obtained from cranial magnetic resonance imaging, cerebrospinal fluid examination, and urine organic acid analysis, as well as the spectral analyses of blood ammonia, blood lactic acid, blood amino acids, and acylcarnitines. Gene detection revealed a de novo heterozygous mutation, c.607G>A (p.G203R), in GNAO1. The girl was then diagnosed with GNAO1-associated early infantile epileptic encephalopathy (EIEE type 17). The seizures were well controlled by topiramate and vigabatrin, but there was no improvement in psychomotor development. She also suffered from recurrent pulmonary infection and died at the age of 12 months due to severe pneumonia. For children with unexplained early infantile epileptic encephalopathy, GNAO1 gene mutations should be considered and genetic tests should be performed as early as possible. Recurrent pulmonary infection should also be taken seriously.
IONG Juan,PENG Jing,DUAN Hao-Lin et al. Recurrent convulsion and pulmonary infection complicated by psychomotor retardation in an infant[J]. CJCP, 2018, 20(2): 154-157.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies:Position paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia, 2017, 58(4):512-521.
[2]
Arya R, Spaeth C, Gilbert DL, et al. GNAO1-associated epileptic encephalopathy and movement disorders:c.607G>A variant represents a probable mutation hotspot with a distinct phenotype[J]. Epileptic Disord, 2017, 19(1):67-75.
[3]
Arafat A, Jing P, Ma Y, et al. Unexplained early infantile epileptic encephalopathy in Han Chinese children:Next-generation sequencing and phenotype enriching[J]. SciRep, 2017, 7:46227.
[4]
McTague A, Howell KB, Cross JH, et al. The genetic landscape of the epileptic encephalopathies of infancy and childhood[J]. Lancet Neurol, 2016, 15(3):304-316.
[5]
Nakamura K, Kodera H, Akita T, et al. De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy[J]. Am J Hum Genet, 2013, 93(3):496-505.
[6]
Pearson TS, Helbig I. Epileptic encephalopathy, movement disorder, and the yin and yang of GNAO1 function[J]. Neurology, 2017, 89(8):754-755.
[7]
Jiang M, Gold MS, Boulay G, et al. Multiple neurological abnormalities in mice deficient in the G protein Go[J]. Proc Natl Acad Sci U S A,1998, 95(6):3269-3274.
[8]
Saitsu H, Fukai R, Ben-Zeev B, et al. Phenotypic spectrum of GNAO1 variants:epileptic encephalopathy to involuntary movements with severe developmental delay[J]. Eur J Hum Genet, 2016, 24(1):129-134.
[9]
Schorling D, Dietel T, Evers C, et al. Expanding phenotype of de novo mutations in GNAO1:Four new cases and review of literature[J]. Neuropediatrics, 2017, 48(5):371-377.
[10]
Talvik I, Møller RS, Vaher M, et al. Clinical phenotype of de novo GNAO1 mutation:Case reort and review of literature[J]. Child Neurol Open, 2015, 2(2):2329048X15583717.
[11]
Yu Y, Huang Z, Mao Z, et al. Go is required for the release of IL-8 and TNF-α, but not degranulation in human mast cells[J].Eur J Pharmacol, 2016, 780:115-121.
